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SUMMARY. The pharmacokinetics of lansoprazole after a single intravenous dose of 30 mg was deter-
mined in 10 healthy volunteers and 10 peptic ulcers patients. In this work, a liquid-liquid extraction and
enrichment method with RP-HPLC determination route was taken with high sensitivity and low limit de-
tection of 5 ng/mL. The concentration-time curves in the two groups were best fitted to a two-compart-
ment model, but their main kinetic parameters were remarkably different between healthy and ulcers vol-
unteers. The mean maximum plasma concentration (Cmax) and area under the curve (AUC0→t) were in-
creased from 975.8 ng/mL to 1298.7 ng/mL and from 1439 ng·h/mL to 2301 ng·h/mL, respectively, and
peak time (tmax) decreased from 0.36 h to 0.26 h. Meanwhile, the half life (t1/2) prolonged from 2.25 h to
2.91 h and the clearance (CL) reduced from 20.04 L/h to 13.96 L/h. That variability of lansoprazole phar-
makinetic parameter indicates that ulcers have significant effect on its metabolic process.
